Ryan Powers M.D.

I am a licensed physician and resident in psychiatry at The Mount Sinai Hospital in New York City offering treatment to adults age 18 and older, including individual therapy, couples therapy, and medication management where appropriate. My overall approach is integrative, drawing on psychology, neuroscience, cutting-edge therapeutics, and established techniques to provide care that is both effective and personalized. I have a particular focus on treatment-resistant depression, helping those with histories of emotional trauma, and guiding patients through the process of transitioning off medications (de-prescribing).

My psychotherapeutic approach emphasizes curiosity and self-exploration within a reliable and supportive therapeutic relationship. I help patients work through experiences and emotions that have previously felt too difficult to confront, fostering a deeper understanding of themselves and their life experiences. Through this process, patients gain access to lost or forgotten aspects of themselves while learning to release what is beyond their control. The result is a more textured, grounded, and vital sense of self. Medications—prescribed at the lowest effective dose—can serve as valuable adjuncts to reduce suffering, improve functioning, and support therapeutic progress. I am skilled in their careful use and have helped many patients streamline or even discontinue medication regimens.

In couples therapy, I help partners cultivate greater intimacy and fulfillment in their relationships. Each person carries a unique, internalized template for intimate connection, shaped in childhood and further developed through later relationships. At times, two partners’ templates may interact in ways that create cycles of increasing distance, even when both long for closeness. I help couples recognize and understand these dynamics, safely explore negative interaction patterns, and develop new ways of relating that honor individual needs while fostering openness and connection.

I am also experienced in helping patients find relief from anxiety disorders, depression and bipolar disorder, ADHD, OCD, schizophrenia and other disorders of psychosis, agoraphobia, and dissociative disorders.

I am currently a senior resident in the Adult Psychiatry Residency Program at Mount Sinai Hospital. I have completed additional training in psychoanalytic therapy through the William Alanson White Institute and the New York Psychoanalytic Society and Institute, as well as training in MDMA-assisted psychotherapy. I earned my medical degree from Dartmouth’s Geisel School of Medicine, where I conducted research on depression in patients with multiple sclerosis. Before medical school, I worked at UC San Francisco’s Memory and Aging Center under Dr. Adam Boxer, studying emerging therapeutics for Alzheimer’s disease and other neurodegenerative disorders. I hold a BA in molecular biology from the University of Pennsylvania.

Supplemental Training:

• Fellowship in Psychoanalysis at The New York Psychoanalytic Society and Institute

• Preparatory Program in Psychoanalysis at The New York Psychoanalytic Society and Institute

• Intensive Psychoanalytic Psychotherapy Program at The William Alanson White Institute

• MAPS MDMA-Assisted Therapy Training Program

• Accelerated Experiential Dynamic Psychotherapy (AEDP) Training with Diana Fosha, PhD and Mark Green, MD

• Couple’s and Family Therapy with Barbara Feld, SW

• Interventional Psychiatry Training (DBS, TMS, Ketamine) with Dr. Andrew Smith, MD

Professional Organizations:

• The American Psychiatric Association

• New York County Psychiatric Society

• The Psychopharmacology Institute

Research Publications:

• Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical Trial. JAMA Neurology, 2020

• An 8-week, open-label, dose-finding study of nimodipine for the treatment of progranulin insufficiency from GRN gene mutations. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2017